论文部分内容阅读
目的:分析丹参川芎嗪(血通注射液)对于脑供血不足眩晕患者的临床治疗效果。方法:从2013年11月到2014年11月于我院治疗的眩晕患者中选取80例脑供血不足型眩晕患者作为研究对象,随机分成采用采用丹参注射液的对照组(40例)与采用丹参川芎嗪注射用的观察组(40例)。观察两组治疗效果,比较不同方案的疗效。结果:观察组治愈28例(70.0%),好转10例(25.0%),无效1例(5.0%),总有效率95.0%;对照组治愈21例(52.5%),好转14例(35.0%),无效5例(12.5%),总有效率87.5%。观察组疗效更为显著(p<0.05)。此外两组患者不良反应情况无统计差异(p>0.05)。结论:丹参川芎嗪注射液对于脑供血不足性眩晕具有良好疗效,提高治愈率,促进患者恢复,值得推广。
Objective: To analyze the clinical effect of ligustrazine (XueTong Injection) on patients with cerebral insufficiency and vertigo. Methods: From November 2013 to November 2014 in our hospital for treatment of vertigo patients selected 80 cases of cerebral insufficiency-type vertigo patients were randomly divided into two groups: control group (40 cases) treated with Salvia miltiorrhiza injection and Salvia miltiorrhiza Ligustrazine injection observation group (40 cases). The two groups were observed the therapeutic effect, compare the curative effect of different programs. Results: The observation group was cured in 28 cases (70.0%), improved in 10 cases (25.0%), ineffective in 1 case (5.0%), the total effective rate was 95.0%; in the control group, 21 cases (52.5% ), 5 cases were ineffective (12.5%), the total effective rate was 87.5%. The observation group was more effective (p <0.05). In addition, there was no statistical difference in adverse reactions between the two groups (p> 0.05). Conclusion: Salviae miltiorrhizae ligustrazine injection has a good curative effect on vertigo of cerebral insufficiency, and it is worth promoting to improve the cure rate and promote the recovery of patients.